Target intelligence / Profile preview

ATP synthase membrane subunit g (ATP5MG)

Target
ATP5MG
Molecular classification
Enzyme complex subunit, ATP synthase subunit, Mitochondrial protein, Other
01

Overview

ATP synthase membrane subunit g (ATP5MG) is a minor yet essential component of the mitochondrial F0 complex, which forms part of the multi-subunit mitochondrial ATP synthase (Complex V) responsible for synthesizing ATP from ADP and inorganic phosphate during oxidative phosphorylation[1][2][3]. ATP5MG is anchored in the inner mitochondrial membrane as part of the proton channel (F0 domain) and likely participates in stabilization, assembly, or regulation of the ATP synthase complex. Mutations in ATP5MG and its related genes can result in mitochondrial diseases marked by disrupted ATP synthesis and energy deficiency. While not typically a standalone drug target, the broader ATP synthase complex can be inhibited by compounds like oligomycin, which impede proton translocation, block ATP production, and cause cellular metabolic collapse if administered systemically[2][3]. ATP5MG is conserved and structurally critical in both normal mitochondrial bioenergetics and in pathologies involving impaired oxidative phosphorylation.

Other names
ATP synthase subunit g 2, mitochondrialATP5MGLATP5K2ATP5L2ATPase subunit g 2dJ222E13.5ATP synthase membrane subunit g-like proteinATP synthase, H+ transporting, mitochondrial F0 complex, subunit G2 pseudogeneputative ATP synthase subunit g 2, mitochondrial
02

Mechanism of action

Drugs like oligomycin inhibit ATP synthase by blocking proton flow through the F0 complex, preventing ATP synthesis[2].

03

Biological functions

ATP synthesisOxidative phosphorylationProton transportMitochondrial energy metabolism
04

Disease associations

Mitochondrial diseaseCombined oxidative phosphorylation deficiencyOther
05

Safety considerations

Inhibition or dysfunction may lead to severe mitochondrial energy deficiency with systemic consequencesTargeting ATP synthase broadly is a challenge due to fundamental energy production role in healthy tissues
06

Interacting drugs

oligomycin
07

Biomarkers

Mutations in ATP5MG

Beyond the preview

Go deeper on ATP synthase membrane subunit g (ATP5MG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP synthase membrane subunit g (ATP5MG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call